Accelerated high-frequency repetitive transcranial magnetic stimulation enhances motor activity in rats

Neuroscience

Volumn 347, Issue , 2017, Pages 103-110

  El Arfani, Anissa ^a   Parthoens, Joke ^b   Demuyser, Thomas ^a   Servaes, Stijn ^b   De Coninck, Mattias ^c   De Deyn, Peter Paul ^c,d   Van Dam, Debby ^c   Wyckhuys, Tine ^b   Baeken, Chris ^e,f   Smolders, Ilse ^a   Staelens, Steven ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f GHENT UNIVERSITY   (Belgium)

Author keywords

accelerated HF rTMS; brain; FDG PET; monoamines; motor activity

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; BRAIN MONOAMINE; DOPAMINE; SEROTONIN; BIOGENIC AMINE; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; CORPUS STRIATUM; GLUCOSE METABOLISM; HIGH FREQUENCY ELECTROTHERAPY; MALE; METABOLITE; MOTOR ACTIVITY; NEUROCHEMISTRY; NONHUMAN; OPEN FIELD TEST; RAT; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; ANIMAL; BRAIN; BRAIN CHEMISTRY; METABOLISM; POSITRON EMISSION TOMOGRAPHY; SPRAGUE DAWLEY RAT; TRANSCRANIAL DIRECT CURRENT STIMULATION;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BIOGENIC MONOAMINES; BRAIN; BRAIN CHEMISTRY; DOPAMINE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HYDROXYINDOLEACETIC ACID; MALE; MOTOR ACTIVITY; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TRANSCRANIAL DIRECT CURRENT STIMULATION;

EID: 85014420401     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2017.01.045     Document Type: Article

References (46)

1. Baeken, C., Marinazzo, D., Everaert, H., Wu, G.R., Van Hove, C., Audenaert, K., Goethals, I., De Vos, F., Peremans, K., De Raedt, R., The impact of accelerated HF-rTMS on the subgenual anterior cingulate cortex in refractory unipolar major depression: insights from (18)FDG PET brain imaging. Brain Stimul, 2015.
2. Baeken, C., De Raedt, R., Van Hove, C., Clerinx, P., De Mey, J., Bossuyt, A., HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging. CNS Spectr 14 (2009), 439–448.
3. Baeken, C., De Raedt, R., Santermans, L., Zeeuws, D., Vanderhasselt, M.A., Meers, M., Vanderbruggen, N., HF-rTMS treatment decreases psychomotor retardation in medication-resistant melancholic depression. Prog Neuropsychopharmacol Biol Psychiatry 34 (2010), 684–687.
4. Baeken, C., De Raedt, R., Bossuyt, A., Van Hove, C., Mertens, J., Dobbeleir, A., Blanckaert, P., Goethals, I., The impact of HF-rTMS treatment on serotonin (2A) receptors in unipolar melancholic depression. Brain Stimul 4 (2011), 104–111.
5. Baeken, C., Schrijvers, D.L., Sabbe, B.G., Vanderhasselt, M.A., De Raedt, R., Impact of one HF-rTMS session on fine motor function in right-handed healthy female subjects: a comparison of stimulation over the left versus the right dorsolateral prefrontal cortex. Neuropsychobiology 65 (2012), 96–102.
6. Baeken, C., Vanderhasselt, M.A., Remue, J., Herremans, S., Vanderbruggen, N., Zeeuws, D., Santermans, L., De Raedt, R., Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients. J Affect Disord 151 (2013), 625–631.
7. Baeken, C., Marinazzo, D., Wu, G.R., Van Schuerbeek, P., De Mey, J., Marchetti, I., Vanderhasselt, M.A., Remue, J., Luypaert, R., De Raedt, R., Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity. World J Biol Psychiatry 15 (2014), 286–297.
8. Ben-Shachar, D., Belmaker, R.H., Grisaru, N., Klein, E., Transcranial magnetic stimulation induces alterations in brain monoamines. J Neural Transm 104 (1997), 191–197.
9. Ben-Shachar, D., Gazawi, H., Riboyad-Levin, J., Klein, E., Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Res 816 (1999), 78–83.
10. Berlim, M.T., Turecki, G., Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatry 52 (2007), 46–54.
11. Berlim, M.T., Turecki, G., What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol 17 (2007), 696–707.
12. Berlim, M.T., Van den Eynde, F., Daskalakis, Z.J., Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials. Depress Anxiety 30 (2013), 614–623.
13. Brus, R., Nowak, P., Szkilnik, R., Mikolajun, U., Kostrzewa, R.M., Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity. Neurotox Res 6 (2004), 317–325.
14. Buyukdura, J.S., McClintock, S.M., Croarkin, P.E., Psychomotor retardation in depression: biological underpinnings, measurement, and treatment. Prog Neuropsychopharmacol Biol Psychiatry 35 (2011), 395–409.
15. Deleye, S., Verhaeghe, J., wyffels, L., Dedeurwaerdere, S., Stroobants, S., Staelens, S., Towards a reproducible protocol for repetitive and semi-quantitative rat brain imaging with (18) F-FDG: exemplified in a memantine pharmacological challenge. NeuroImage 96 (2014), 276–287.
16. Drevets, W.C., Savitz, J., Trimble, M., The subgenual anterior cingulate cortex in mood disorders. CNS Spectr 13 (2008), 663–681.
17. El Arfani, A., Bentea, E., Aourz, N., Ampe, B., De Deurwaerdère, P., Van Eeckhaut, A., Massie, A., Sarre, S., Smolders, I., Michotte, Y., NMDA receptor antagonism potentiates the L-DOPA-induced extracellular dopamine release in the subthalamic nucleus of hemi-parkinson rats. Neuropharmacology 85 (2014), 198–205.
18. Hadley, D., Anderson, B.S., Borckardt, J.J., Arana, A., Li, X., Nahas, Z., George, M.S., Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT 27 (2011), 18–25.
19. Hoeppner, J., Padberg, F., Domes, G., Zinke, A., Herpertz, S.C., Grossheinrich, N., Herwig, U., Influence of repetitive transcranial magnetic stimulation on psychomotor symptoms in major depression. Eur Arch Psychiatry Clin Neurosci 260 (2010), 197–202.
20. Holtzheimer, P.E., McDonald, W.M., Mufti, M., Kelley, M.E., Quinn, S., Corso, G., Epstein, C.M., Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depress Anxiety 27 (2010), 960–963.
21. Izurieta-Sánchez, P., Sarre, S., Ebinger, G., Michotte, Y., Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of L-dopa in hemi-Parkinson rats. Eur J Pharmacol 353 (1998), 33–42.
22. Kanno, M., Matsumoto, M., Togashi, H., Yoshioka, M., Mano, Y., Effects of acute repetitive transcranial magnetic stimulation on dopamine release in the rat dorsolateral striatum. J Neurol Sci 217 (2004), 73–81.
23. Keck, M.E., Sillaber, I., Ebner, K., Welt, T., Toschi, N., Kaehler, S.T., Singewald, N., Philippu, A., Elbel, G.K., Wotjak, C.T., Holsboer, F., Landgraf, R., Engelmann, M., Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. Eur J Neurosci 12 (2000), 3713–3720.
24. Keck, M.E., Welt, T., Müller, M.B., Erhardt, A., Ohl, F., Toschi, N., Holsboer, F., Sillaber, I., Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 43 (2002), 101–109.
25. Kito, S., Hasegawa, T., Koga, Y., Cerebral blood flow ratio of the dorsolateral prefrontal cortex to the ventromedial prefrontal cortex as a potential predictor of treatment response to transcranial magnetic stimulation in depression. Brain Stimul 5 (2012), 547–553.
26. Knoch, D., Treyer, V., Regard, M., Muri, R.M., Buck, A., Weber, B., Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow. NeuroImage 31 (2006), 641–648.
27. Lefaucheur, J.P., Andre-Obadia, N., Antal, A., Ayache, S.S., Baeken, C., Benninger, D.H., Cantello, R.M., Cincotta, M., de Carvalho, M., De Ridder, D., Devanne, H., Di Lazzaro, V., Filipovic, S.R., Hummel, F.C., Jaaskelainen, S.K., Kimiskidis, V.K., Koch, G., Langguth, B., Nyffeler, T., Oliviero, A., Padberg, F., Poulet, E., Rossi, S., Rossini, P.M., Rothwell, J.C., Schonfeldt-Lecuona, C., Siebner, H.R., Slotema, C.W., Stagg, C.J., Valls-Sole, J., Ziemann, U., Paulus, W., Garcia-Larrea, L., Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol 125 (2014), 2150–2206.
28. Luft, A.R., Kaelin-Lang, A., Hauser, T.K., Cohen, L.G., Thakor, N.V., Hanley, D.F., Transcranial magnetic stimulation in the rat. Exp Brain Res 140 (2001), 112–121.
29. Maurice, N., Olry, J.C., Cariou, R., Dervilly-Pinel, G., Le Bizec, B., Travel, A., Jondreville, C., Schroeder, H., Short-term effects of a perinatal exposure to the HBCDD alpha-isomer in rats: assessment of early motor and sensory development, spontaneous locomotor activity and anxiety in pups. Neurotoxicol Teratol 52 (2015), 170–180.
30. Micallef-Trigona, B., Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depress Res Treat, 2014, 2014, 135049.
31. Mills, K.R., Nithi, K.A., Corticomotor threshold to magnetic stimulation: normal values and repeatability. Muscle Nerve 20 (1997), 570–576.
32. Mitchell, P.B., Loo, C.K., Transcranial magnetic stimulation for depression. Aust N Z J Psychiatry 40 (2006), 406–413.
33. Parthoens, J., Verhaeghe, J., Stroobants, S., Staelens, S., Deep brain stimulation of the prelimbic medial prefrontal cortex: quantification of the effect on glucose metabolism in the rat brain using [(18) F]FDG microPET. Mol Imaging Biol 16 (2014), 838–845.
34. 1⁸F]-FDG microPET to quantify the neuromodulation effect in the rat brain. Neuroscience 275 (2014), 436–443.
35. Parthoens, J., Verhaeghe, J., Servaes, S., Miranda, A., Stroobants, S., Staelens, S., Performance characterization of an actively cooled repetitive transcranial magnetic stimulation coil for the rat. Neuromodulation, 2016.
36. Pogarell, O., Koch, W., Pöpperl, G., Tatsch, K., Jakob, F., Zwanzger, P., Mulert, C., Rupprecht, R., Möller, H.J., Hegerl, U., Padberg, F., Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res 40 (2006), 307–314.
37. Sabbe, B., Hulstijn, W., Maes, M., Pier, M., Scharpé, S., Zitman, F., Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers. Psychiatry Res 105 (2001), 151–163.
38. Sibon, I., Strafella, A.P., Gravel, P., Ko, J.H., Booij, L., Soucy, J.P., Leyton, M., Diksic, M., Benkelfat, C., Acute prefrontal cortex TMS in healthy volunteers: effects on brain 11C-alphaMtrp trapping. NeuroImage 34 (2007), 1658–1664.
39. Smolders, I., Clinckers, R., Meurs, A., De Bundel, D., Portelli, J., Ebinger, G., Michotte, Y., Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action. Neuropharmacology 54 (2008), 1017–1028.
40. Strafella, A.P., Paus, T., Barrett, J., Dagher, A., Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci, 21, 2001, RC157.
41. Tadaiesky, M.T., Dombrowski, P.A., Figueiredo, C.P., Cargnin-Ferreira, E., Da Cunha, C., Takahashi, R.N., Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. Neuroscience 156 (2008), 830–840.
42. van Londen, L., Kerkhof, G.A., van den Berg, F., Goekoop, J.G., Zwinderman, K.H., Frankhuijzen-Sierevogel, A.C., Wiegant, V.M., de Wied, D., Plasma arginine vasopressin and motor activity in major depression. Biol Psychiatry 43 (1998), 196–204.
43. Volkers, A.C., Tulen, J.H., van den Broek, W.W., Bruijn, J.A., Passchier, J., Pepplinkhuizen, L., Motor activity and autonomic cardiac functioning in major depressive disorder. J Affect Disord 76 (2003), 23–30.
44. Wu, K., Gao, X., Shi, B., Chen, S., Zhou, X., Li, Z., Gan, Y., Cui, L., Kang, J.X., Li, W., Huang, R., Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease. Neuroscience 333 (2016), 345–355.
45. Yuuki, N., Ida, I., Oshima, A., Kumano, H., Takahashi, K., Fukuda, M., Oriuchi, N., Endo, K., Matsuda, H., Mikuni, M., HPA axis normalization, estimated by DEX/CRH test, but less alteration on cerebral glucose metabolism in depressed patients receiving ECT after medication treatment failures. Acta Psychiatr Scand 112 (2005), 257–265.
46. Zeeuws, D., De Rycker, K., De Raedt, R., De Beyne, M., Baeken, C., Vanderbruggen, N., Intensive high-frequency repetitive transcranial magnetic stimulation treatment in an electroconvulsive shock therapy-resistant bipolar I patient with mixed episode. Brain Stimul 4 (2011), 46–49.